The O’Neil Review on antimicrobial resistance (AMR) has highlighted the important role that point-of-care diagnostic devices could play in tackling AMR.
The report ‘Rapid Diagnostics: Transforming Antibiotic Use to Curb the Tide of Resistance,’ is the fourth paper published by the independent Review on Antimicrobial Resistance. It addresses the potential contribution of testing and diagnostics in the fight against AMR and highlights the role that testing, particularly rapid point-of-care testing, could play in treating bacterial infections better; slowing the rise of drug-resistance by reducing the unnecessary use of antimicrobials, in particular antibiotics; and changing the approach to treating bacterial infections through targeted and precise therapies.
Previous reviews have estimated that drug-resistant infections could kill an extra 10 million people across the world every year by 2050 if the issue is not addressed.
It has already been well documented that the supply of new medicines is insufficient to keep pace with the increase in drug resistance, as older medicines are being used more widely and microbes evolve to resist them.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
